ClinConnect ClinConnect Logo
Search / Trial NCT06931665

Neurological and Physiological Effects of Animal-assisted Therapy for Patients in a Minimally Conscious State

Launched by UNIVERSITY OF BASEL · Apr 16, 2025

Trial Information

Current as of June 26, 2025

Not yet recruiting

Keywords

ClinConnect Summary

This clinical trial is studying how Animal-Assisted Therapy (AAT) might help patients who are in a minimally conscious state (MCS). MCS means that a person has some awareness of their surroundings but is not fully conscious. The researchers will look at brain activity using a method called electroencephalogram (EEG) to see if AAT can increase brain complexity, which is important for understanding consciousness. They will also measure heart activity, skin responses, and observe behaviors to get a full picture of how AAT affects these patients.

To participate in this trial, patients need to be inpatients with an acquired brain injury, either from an accident or another cause. They must be 18 years or older and have a diagnosis of MCS. It's important that they are stable and that their legal representative gives consent for them to join. However, those with allergies to animals involved in the therapy, certain medical conditions, or significant medication changes won't be eligible. Participants can expect to engage with animals in a therapeutic setting, and the study aims to gather valuable information that could improve care for people in similar situations.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Inpatients in one of the study sites
  • Acquired brain injury resulting from either traumatic or non-traumatic events
  • Diagnosis of MCS defined by CRS-R according to the Aspen criteria (Giacino, 2005)
  • Informed consent as documented by signature by the patient's legal representative
  • Physiologically stable
  • Aged 18 or over
  • Exclusion Criteria:
  • Phobia or allergies to any of the involved animals
  • Medical contraindications: acute or chronic disease (e.g. chronic pain, hypertension, heart disease, renal disease, liver disease, diabetes)
  • Radical changes in medication (decision made with responsible physician)

About University Of Basel

The University of Basel, established in 1460, is one of the oldest and most prestigious universities in Switzerland, renowned for its commitment to research and education in the life sciences, medicine, and clinical research. As a clinical trial sponsor, the university leverages its multidisciplinary expertise and state-of-the-art facilities to advance innovative therapeutic approaches and improve patient care. The University of Basel fosters collaboration among leading scientists, healthcare professionals, and industry partners, ensuring rigorous adherence to ethical standards and regulatory requirements in all clinical trials. Through its comprehensive research programs, the university aims to contribute significantly to the understanding and treatment of various medical conditions, ultimately enhancing global health outcomes.

Locations

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported